143

Neurology
Focuses on brain health.
Sub Categories on Neurology
Latest Articles
New insights into the role of the different meningeal layers in autoimmune-inflammatory diseases

New insights into the role of the different meningeal layers in autoimmune-inflammatory diseases

by Stefan Weller, Universitätsmedizin Göttingen - Georg-August-UniversitätAuthors of the publication: (f. l.) Prof. Dr. Alexander Flügel (Institute Director), Dr. Arianna Merlini (First author, postdo

New insights into the role of the different meningeal layers in autoimmune-inflammatory diseases

by Stefan Weller, Universitätsmedizin Göttingen - Georg-August-UniversitätAuthors of the publication: (f. l.) Prof. Dr. Alexander Flügel (Institute Director), Dr. Arianna Merlini (First author, postdo
New drug candidate ameliorates Alzheimer's and other brain diseases

New drug candidate ameliorates Alzheimer's and other brain diseases

by Ludwig Maximilian University of MunichCredit: Jens WagnerProfessor Armin Giese from the Center for Neuropathology and Prion Research at the LMU Munich and researchers at the Max Planck Institu

New drug candidate ameliorates Alzheimer's and other brain diseases

by Ludwig Maximilian University of MunichCredit: Jens WagnerProfessor Armin Giese from the Center for Neuropathology and Prion Research at the LMU Munich and researchers at the Max Planck Institu
Researchers find new origin of deep brain waves

Researchers find new origin of deep brain waves

byUniversity of California, IrvineSpindle frequencies embedded in the spike train. (A) Raw data of single axon from CA3 feedback to DG (F12-G12) channels, array ECDGCA3CA1 19908 160518 160610 d2

Researchers find new origin of deep brain waves

byUniversity of California, IrvineSpindle frequencies embedded in the spike train. (A) Raw data of single axon from CA3 feedback to DG (F12-G12) channels, array ECDGCA3CA1 19908 160518 160610 d2
Unlocking how the new Alzheimer's drug lecanemab works

Unlocking how the new Alzheimer's drug lecanemab works

by Rockefeller UniversityA false-color SEM image of a fibrin blood clot before and after the buildup of amyloid-beta proteins called protofibrils. Credit: Pradeep Singh, PhD; Images collected at

Unlocking how the new Alzheimer's drug lecanemab works

by Rockefeller UniversityA false-color SEM image of a fibrin blood clot before and after the buildup of amyloid-beta proteins called protofibrils. Credit: Pradeep Singh, PhD; Images collected at
Brain stimulation can rewire and heal damaged neural connections, but it isn't clear how

Brain stimulation can rewire and heal damaged neural connections, but it isn't clear how

by Azadeh Yazdan-Shahmorad, Alec Greaves-Tunnell and Julien Bloch,The ConversationDeep-brain stimulation is one form of neurostimulation currently used to treat Parkinson’s and depression.The co

Brain stimulation can rewire and heal damaged neural connections, but it isn't clear how

by Azadeh Yazdan-Shahmorad, Alec Greaves-Tunnell and Julien Bloch,The ConversationDeep-brain stimulation is one form of neurostimulation currently used to treat Parkinson’s and depression.The co
Are the olfactory responses of patients in a coma or vegetative state signs of consciousness?

Are the olfactory responses of patients in a coma or vegetative state signs of consciousness?

by Ingrid Fadelli , Medical XpressBehavioral results and global connectivity among HCs, ORES, and N-ORES. (A) The proportion of olfactory response among MCS and VS/UWS patients. A relationship was obs

Are the olfactory responses of patients in a coma or vegetative state signs of consciousness?

by Ingrid Fadelli , Medical XpressBehavioral results and global connectivity among HCs, ORES, and N-ORES. (A) The proportion of olfactory response among MCS and VS/UWS patients. A relationship was obs
Biogen pulls controversial Alzheimer's drug Aduhelm

Biogen pulls controversial Alzheimer's drug Aduhelm

Biogen said it was discontinuing Aduhelm to put more resources into Leqembi, a newer Alzheimer's medicine that was fully approved in 2023 under the traditional regulatory pathway.A controversial A

Biogen pulls controversial Alzheimer's drug Aduhelm

Biogen said it was discontinuing Aduhelm to put more resources into Leqembi, a newer Alzheimer's medicine that was fully approved in 2023 under the traditional regulatory pathway.A controversial A
Constipation may be a marker for dementia risk

Constipation may be a marker for dementia risk

by Amy NortonChronic constipation may not only be an indicator of gut health, but a potential warning sign of thinking declines, a preliminary study suggests.Researchers found that among more than 110

Constipation may be a marker for dementia risk

by Amy NortonChronic constipation may not only be an indicator of gut health, but a potential warning sign of thinking declines, a preliminary study suggests.Researchers found that among more than 110
When does the brain process reward and risk? Neuroscientists test a computational model

When does the brain process reward and risk? Neuroscientists test a computational model

by Cynthia Eller,California Institute of TechnologyNeural activity in a region of the brain called the anterior insula could utilize a representation of RePE to then decode RiPE at a later time.

When does the brain process reward and risk? Neuroscientists test a computational model

by Cynthia Eller,California Institute of TechnologyNeural activity in a region of the brain called the anterior insula could utilize a representation of RePE to then decode RiPE at a later time.
COVID-19 lockdowns linked to less accurate recollection of event timing

COVID-19 lockdowns linked to less accurate recollection of event timing

byPublic Library of ScienceSimilar to a landscape where objects/people are placed in relation to others, a timescape puts the event timeline in relation to other events. Credit: Arianna Sahraie

COVID-19 lockdowns linked to less accurate recollection of event timing

byPublic Library of ScienceSimilar to a landscape where objects/people are placed in relation to others, a timescape puts the event timeline in relation to other events. Credit: Arianna Sahraie
FDA grants orphan drug designation to potential treatment of STXBP1 developmental and epileptic encephalopathy

FDA grants orphan drug designation to potential treatment of STXBP1 developmental and epileptic encephalopathy

by Graciela Gutierrez,Baylor College of MedicineDNA, which has a double-helix structure, can have many genetic mutations and variations. Credit: NIHResearch that was carried out by Baylor Colleg

FDA grants orphan drug designation to potential treatment of STXBP1 developmental and epileptic encephalopathy

by Graciela Gutierrez,Baylor College of MedicineDNA, which has a double-helix structure, can have many genetic mutations and variations. Credit: NIHResearch that was carried out by Baylor Colleg
Computer avatars play a part in dementia detection

Computer avatars play a part in dementia detection

by Osaka UniversityFigure 1. Human-Avatar Dialogue System. Figure 1. Human-Avatar Dialogue System: (a)Introduction “What’s your name?”(b) Gaze measurement(c) Reading test(d) Fixed question “What’

Computer avatars play a part in dementia detection

by Osaka UniversityFigure 1. Human-Avatar Dialogue System. Figure 1. Human-Avatar Dialogue System: (a)Introduction “What’s your name?”(b) Gaze measurement(c) Reading test(d) Fixed question “What’